Surgical treatment of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) represents an aggressive tumor of the digestive system with still low five-year survival of less than 10%. Although there are improvements for multimodal therapy of PDAC, surgery still remains the effective way to treat the disease. Combined with adjuvant and/...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 April 2021
|
| In: |
Cancers
Year: 2021, Volume: 13, Issue: 8, Pages: 1-16 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers13081971 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers13081971 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/13/8/1971 
|
| Author Notes: | Kongyuan Wei and Thilo Hackert |
| Summary: | Pancreatic ductal adenocarcinoma (PDAC) represents an aggressive tumor of the digestive system with still low five-year survival of less than 10%. Although there are improvements for multimodal therapy of PDAC, surgery still remains the effective way to treat the disease. Combined with adjuvant and/or neoadjuvant treatment, pancreatic surgery is able to enhance the five-year survival up to around 20%. However, pancreatic resection is always associated with a high risk of complications and regarded as one of the most complex fields in abdominal surgery. This review gives a summary on the surgical treatment for PDAC based on the current literature with a special focus on resection techniques. |
|---|---|
| Item Description: | Gesehen am 01.06.2021 |
| Physical Description: | Online Resource |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers13081971 |